First Time Loading...

Dermapharm Holding SE
XETRA:DMP

Watchlist Manager
Dermapharm Holding SE Logo
Dermapharm Holding SE
XETRA:DMP
Watchlist
Price: 33.5 EUR 4.36% Market Closed
Updated: May 4, 2024

Dermapharm Holding SE
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Dermapharm Holding SE
Revenue Peer Comparison

Comparables:
ATAI
BAYN
MRK
93M1
PSG

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Dermapharm Holding SE
XETRA:DMP
Revenue
€1.1B
CAGR 3-Years
13%
CAGR 5-Years
15%
CAGR 10-Years
N/A
ATAI Life Sciences NV
NASDAQ:ATAI
Revenue
$314k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bayer AG
XETRA:BAYN
Revenue
€47.6B
CAGR 3-Years
5%
CAGR 5-Years
5%
CAGR 10-Years
2%
Merck KGaA
XETRA:MRK
Revenue
€21B
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
7%
MPH Health Care AG
XETRA:93M1
Revenue
€37.4k
CAGR 3-Years
-5%
CAGR 5-Years
-39%
CAGR 10-Years
N/A
PharmaSGP Holding SE
XETRA:PSG
Revenue
€85.8m
CAGR 3-Years
11%
CAGR 5-Years
10%
CAGR 10-Years
N/A

See Also

What is Dermapharm Holding SE's Revenue?
Revenue
1.1B EUR

Based on the financial report for Dec 31, 2023, Dermapharm Holding SE's Revenue amounts to 1.1B EUR.

What is Dermapharm Holding SE's Revenue growth rate?
Revenue CAGR 5Y
15%

Over the last year, the Revenue growth was 11%. The average annual Revenue growth rates for Dermapharm Holding SE have been 13% over the past three years , 15% over the past five years .